February 21-22, 2013
Agenda
Thursday, February 21
8:30 a.m. |
Welcome and Introductions Pamela Marino, Ph.D. |
---|---|
|
|
Historical Perspective | |
|
|
9:00 a.m. | From Humble Observations to Novel Antimicrobials: Learning from Mother’s Milk Glycans |
|
|
Antimicrobial Activity of Glycans in Human Milk | |
|
|
9:30 a.m. |
Four Mechanisms of Human Milk Oligosaccharide Bioactivity |
|
|
10:00 a.m. |
Inhibition of Rotavirus Binding and Infectivity by Human Milk Oligosaccharides In Vitro and In Vivo |
|
|
10:30 a.m. |
Break |
|
|
10:45 a.m. |
Hyaluronan-Mediated Induction of Antimicrobial Peptides and Epithelial Cell Protection from Salmonella Infection |
|
|
11:15 a.m. |
Human Milk Oligosaccharides (HMOs), E. histolytica Amebiasis, and Necrotizing Enterocolitis |
|
|
11:45 a.m. | Panel Discussion |
|
|
12:15 p.m. |
Lunch |
|
|
Screens for Detection of Antimicrobial Activity | |
|
|
1:15 p.m. |
Screens for Rapid Detection of Antimicrobial Activity of Human Milk Glycans and Detection of Milk Glycan Recognition by Microbes |
|
|
1:45 p.m. |
One-Pot Multienzyme Synthesis of Human Milk Oligosaccharides and Exploration of Their Antimicrobial Activities |
|
|
2:15 p.m. |
Detection and quantification of HMO-protein interactions using Electrospray Ionization Mass Spectrometry ESI-MS |
|
|
2:45 p.m. |
On Glycan Density: Characterizing Carbohydrate-Mediated Host-Pathogen Interactions via Glycan Biosensors |
|
|
3:15 p.m. |
Break |
|
|
High Throughput Isolation and Structural Analysis of Human Milk Glycans (HMGs) | |
|
|
3:30 p.m. | Determination and Quantitation of Human Milk Oligosaccharides in Human Fluids |
|
|
Synthetic Methods to Generate HMGs for Preclinical Testing | |
|
|
4:00 p.m. |
Comparison and Perspectives of Several Approaches to Produce Human Milk Oligosaccharides |
|
|
4:30 p.m.–5:15 P.M. |
General Discussion and Summary of Day 1 |
|
|
5:15 p.m. |
Adjourn |
Friday, February 22
Synthetic Methods to Generate HMGs for Preclinical Testing (continued) | |
|
|
8:30 a.m. | High-Level Production of Human Milk Oligosaccharides in Engineered E. coli |
---|---|
|
|
9:00 a.m. | Chemoenzymatic Synthesis of Fucosylated Glycans |
|
|
9:30 a.m. |
Chemoenzymatic Synthesis and Purification of Activated Sugar Analogues and Oligosaccharides on a Multi-Gram Scale |
|
|
10:00 a.m. |
Automated Solution-Phase Synthesis of Glycans |
|
|
10:30 a.m. |
Break |
|
|
10:45 a.m. |
Chemo-Enzymatic Synthesis of Asymmetrically Substituted Multi-Antennary Glycans for Probing Structure Activity Relationships |
|
|
Clinical Considerations | |
|
|
11:15 a.m. |
Dietetic Oligosaccharides in Early Nutrition: What Did We Learn from Human Milk Research? |
|
|
11:45 a.m. | General Discussion and Summary of Day 2 |
|
|
12:15 p.m. |
Lunch |
|
|
1:00 p.m. |
Panel Discussion: Barriers Overcome and Barriers Remaining and Recommendations for Next Steps Sharon Donovan, Ph.D. John McCoy, Ph.D. Bernd Stahl, Ph.D. Willie Vann, Ph.D. David Newburg, Ph.D. Dave Smith, Ph.D. |
|
|
2:00 p.m. |
Adjourn |
Return to Workshop on Bioactive Glycans in Human Milk main page.